Lentocilin Injection, Powder, For Suspension
Product Images NDC 84383-110

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lentocilin (NDC 84383-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laborat�rios Atral, S.a., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-vial (Carton Vial)

Lentocilin 1200000 IU/4mL injection powder for suspension vial and packaging. The box and vial label show the brand name Lentocilin with the active ingredient Benzathine benzylpenicillin. The packaging includes the Atral logo and indicates the product contains 1 vial and 1 ampoule (4mL) for injection.*

FDA Label Image

Indications&usage Section (Picture 1)

This is a package leaflet for Lentocilin S injection, powder and solvent for suspension, available in strengths 1,200,000 IU/4 mL and 2,400,000 IU/6.5 mL. It provides detailed user information including uses, dosage instructions, warnings, side effects, precautions, and storage guidance for Lentocilin S containing benzathine benzylpenicillin, indicated for various bacterial infections and prophylaxis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.